LIVZON PHARMA (01513) announced that the company's board of directors received a resignation letter from securities representative Mr. Ye Delong on August 20, 2025. Due to work adjustments, Mr. Ye Delong will no longer serve as the company's securities representative, with his resignation taking effect from the date it was delivered to the board of directors.

The company's board of directors held the 26th meeting of the 11th board on August 20, 2025, and reviewed and approved the "Proposal on Appointing the Company's Securities Representative." The board agreed to appoint Ms. Li Xiaoyu as the company's securities representative to assist the board secretary in fulfilling relevant duties. Her term of appointment will commence from the date of board approval and continue until the expiration of the company's 11th board of directors.